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Abstract
Background: Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome presents with characteristic
clinical manifestations such as aneurysms at arteriolar bifurcations and optic nerve and retinal vascular inflammation.
Regression of such features on treatment with anti-tubercular therapy (ATT) combined with corticosteroids has not
been reported in literature.
Findings: A 30-year-old female with sudden painless decreased vision in the left eye was referred with a diagnosis of
presumed tuberculous retinal vasculitis and a positive tuberculin skin test. Based on the clinical and angiographic
features of the right eye, a diagnosis of IRVAN syndrome was made. In the left eye, the patient had vitreous hemorrhage
for which pars plana vitrectomy was performed. The vitreous sample was positive for Mycobacterium tuberculosis using
multiplex polymerase chain reaction, and the patient was started on standard four-drug ATT and oral corticosteroids. At
6-month follow-up, vanishing of retinal arterial aneurysms was observed.
Conclusions: The pathogenesis of IRVAN syndrome is uncertain. One of the postulates is that the features of arterial
aneurysms and other retinal vascular alterations occur secondary to acquired inflammatory reaction. We hypothesize that
IRVAN syndrome may be a morphological diagnosis possibly associated with various entities, one of which could
be ocular tuberculosis. It may be prudent to rule out intraocular tuberculosis in cases labeled as IRVAN syndrome
in an endemic population.




Idiopathic retinal vasculitis, aneurysms, and neuroretini-
tis (IRVAN) syndrome is a well-defined disease entity,
which is diagnosed on the basis of constellation of clin-
ical features such as retinal vasculitis, aneurysms at ar-
teriolar bifurcations, and neuroretinitis (major criteria).
In addition, patients with IRVAN syndrome may have a
presence of retinal peripheral capillary non-perfusion,
retinal neovascularization, and other secondary vasopro-
liferative complications, and macular exudation (minor
criteria) [1, 2].
Earlier regarded as a benign self-limiting entity, recent
studies have suggested that patients with IRVAN syn-
drome may continue to lose vision if left untreated. Vari-
ous therapeutic regimens have been advocated for the
treatment of IRVAN syndrome, including pan-retinal laser
photocoagulation (PRP), surgery, trans-scleral cryother-
apy, corticosteroid therapy, administration of monoclonal
antibodies such as ranibizumab, and immunomodulatory
therapy [2–4].
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While a number of studies have suggested a diverse range
of treatment options for this condition, the exact pathogen-
esis of IRVAN syndrome still remains unknown. Associa-
tions of IRVAN syndrome with allergic fungal sinusitis [5],
elevated intracranial pressure [6], hyperhomocysteinemia
[7], and p-ANCA [8] have been reported in literature. In
addition, similarities in the pathogenesis of IRVAN syn-
drome and presumed tuberculous retinal vasculitis have
been suggested [9]. We hereby report a case diagnosed as
IRVAN syndrome based on clinical and imaging features,
in which the retinal aneurysms vanished on treatment with
anti-tubercular therapy (ATT).
Case report
A 30-year-old female presented with sudden painless de-
creased vision in the left eye (OS) for the past 1 week.
She was diagnosed elsewhere with presumed tuberculous
retinal vasculitis with positive tuberculin skin test and was
referred to the Retina Clinic, Postgraduate Institute of
Medical Education and Research (PGIMER), Chandigarh,
India, for further management. Her best-corrected visual
acuity (BCVA) was 20/40 in the right eye (OD) and count-
ing fingers close to the face in OS. The pupillary reactions
were normal in both the eyes (OU). Intraocular pressure
was 16 mmHg OU on Goldmann applanation tonometry.
Anterior segment examination on slit-lamp biomicroscopy
was unremarkable OU.
Posterior segment examination showed hard exudates
in the posterior pole and few superficial hemorrhages as-
sociated with “tied-knot-like” aneurysmal dilations of the
arterioles on the optic nerve head and in the surrounding
peripapillary area in OD (Fig. 1a). Fluorescein angiogram
(FA) confirmed the presence of multiple aneurysms along
the retinal arterioles (Fig. 1b–d). There was significant
peripheral retinal non-perfusion in all the four quadrants
OU (Fig. 1d, only the right eye shown). There was a pres-
ence of vitreous hemorrhage, peripapillary fibrovascular
proliferation, sheathed vessels, and a featureless, ischemic
retina in OS. In addition, there were multiple occluded
small vessels in the periphery in OU (Fig. 1a). There was
no evidence of macular edema on optical coherence tom-
ography. Based on the clinical and FA features, diagnosis
of IRVAN syndrome stage 2 in OD and stage 3 in OS was
made [10].
Recording of thorough medical history and systemic
examination to rule out ocular/systemic vasculitis and
connective tissue disorders was performed but was un-
revealing. There was no positive family history. The
systolic and diastolic blood pressures were 116 and
76 mmHg, respectively, and there were no echocardio-
graphic abnormalities. Laboratory investigations includ-
ing chest x-ray and x-ray of the paranasal sinuses
(water’s view), complete blood count, erythrocyte sedi-
mentation rate, routine blood chemistry, complete lipid
profile, urine analysis, carotid Doppler, Treponema pal-
lidum hemagglutination test, anti-nuclear antibody,
anti-double-stranded DNA antibody, anti-phospholipid
antibodies (including anti-cardiolipin and lupus anti-
coagulant), serum homocysteine, anti-neutrophil cyto-
plasmic antibody, and positron emission tomography
were negative. The tuberculin skin test (50 × 51 mm)
and erythrocyte sedimentation rate (40 mm at the end
Fig. 1 Fundus photograph (a) and fluorescein angiogram (FA) (b–d) of the right eye at presentation showing hard exudates, superficial hemorrhages,
and “tied-knot-like” aneurysmal dilatations of the arterioles on optic disc and in the surrounding region. In addition, vascular sheathing can be
observed in the larger vessels temporally. A large area of capillary non-perfusion can be seen temporally on FA (b). In the late phase (d), significant
leakage can be observed from the peripheral vessels at the junction of perfused and non-perfused retina
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of 1 h) were positive. High-resolution contrast-enhanced
chest scan showed calcification in the left lower lobe sug-
gestive of Ghon complex.
Pan-retinal photocoagulation was performed in the area
of avascular peripheral retina in OD. The left eye under-
went pars plana vitrectomy (PPV) and endolaser in the
areas of non-perfusion. A vitreous sample was obtained at
the time of surgery and was preserved for further analysis.
Multiplex polymerase chain reaction (MPCR) was per-
formed on the vitreous sample using a previously de-
scribed technique [11]. The sample was positive for
Mycobacterium tuberculosis (Fig. 2). The diagnosis was re-
vised, and the patient was started on a tapering dose of
oral prednisolone (1 mg/kg) for 3 months along with
standard four-drug anti-tubercular treatment (ATT). At 6-
month follow-up, BCVA improved to 20/20 in OD and
20/40 in OS. Posterior segment examination and FA im-
aging showed resolution of retinal arterial aneurysms in
OU (Fig. 3; only the right eye shown). At the last follow-
up visit, 11 months from the initial presentation, the pa-
tient had a BCVA of 20/20 in both the eyes. The retinal
arterial aneurysms further decreased in number (Fig. 3).
The anti-tubercular therapy is planned to be discontinued
after completion of 1 year.
Discussion
The natural history and pathogenesis of IRVAN syn-
drome has not been clearly elucidated yet. It has been
postulated that the features of arteriolar aneurysms and
other retinal vascular alterations such as occlusion occur
as a result of pathological changes triggered by an ac-
quired inflammatory reaction [9]. Sashihara et al. [12]
have proposed that the presence of anterior chamber
and vitreous cells in certain patients with IRVAN syn-
drome and changes in the morphological appearance
and location of the aneurysms could be the result of a
migratory inflammatory process involving alternate seg-
ments of the retinal vascular network.
Among patients with IRVAN syndrome, this inflamma-
tory process may be activated by hypersensitivity reaction
to tubercular antigens [9]. It has been speculated that the
pathogenesis of IRVAN syndrome may be related to pre-
sumed tuberculous retinal vasculitis since the findings in
IRVAN syndrome resemble those of acquired allergic vas-
cular diseases [9]. Peripheral retinal non-perfusion may
occur in both the entities except for aneurysms at arteri-
olar bifurcations, which are a characteristic feature of
IRVAN syndrome. A number of studies have demon-
strated a strong association between retinal vasculitis and
tuberculosis [13–16]. Thus, IRVAN syndrome can be con-
sidered to be a morphological diagnosis such as serpigin-
ous choroidopathy, which may have various associations
including ocular tuberculosis.
IRVAN was initially thought to be a self-limiting disease.
Chang et al. [1] in 1995 reported a more aggressive course
with devastating visual consequences. Samuel et al. [10]
presented the largest cohort of patients with IRVAN
syndrome and recommended early pan-retinal laser
photocoagulation. All eyes with vitreous hemorrhage
underwent early PPV, and extensive pan-retinal photo-
coagulation was done in the fellow eye [10]. The role of
anti-inflammatory drugs, i.e., steroids, and immunosup-
pressive drugs is still unclear [1, 2]. In the index case,
treatment with ATT and corticosteroids (for the initial
3 months) may have controlled the underlying inflam-
matory/hypersensitivity stimulus resulting in resolution
of arteriolar aneurysms.
Regression of arteriolar aneurysms among patients with
IRVAN syndrome is extremely rare. There are very few
case reports that have demonstrated resolution of aneu-
rysms in the literature [5, 12, 17]. In one of these reports
by Owens and Gregor [17], the arteriolar aneurysms van-
ished over 7 years after the patient underwent surgery for
vitreous hemorrhage. Pan-retinal photocoagulation may
also be associated with regression of retinal aneurysms
in IRVAN [10]. In addition, adjunctive corticosteroid
therapy in our patient may have also played a role in
resolution of aneurysms.
Despite the limitation of being a single case, it is im-
perative to note that our patient had a strongly positive
laboratory assay for tubercular antigens and vitreous
fluid positive for mycobacterium genome using the PCR
Fig. 2 Positive results of multiplex polymerase chain reaction
demonstrating positivity to tubercular antigens in the vitreous fluid.
Band L1 represents 100-bp molecular marker; L2 is the positive control
(asterisk indicates protein B (419 bp), double asterisks indicate MPB64
(240 bp), dagger indicates IS6110 (123 bp)). Band L3 is the negative
control. Bands L4, L5, and L6 represent the positive results obtained
from the vitreous fluid of the patient described in the index case
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technique. While it is possible that the laboratory find-
ings of ocular tuberculosis were coincidental, PCR has
been reported to have a high specificity and positive pre-
dictive value (100 %) [11].
Conclusions
Based on the findings of the index case, we hypothesize
that the morphological features of IRVAN syndrome
may occur as an extended spectrum of ocular tubercu-
losis in endemic regions with high prevalence of the
disease. In conclusion, the index case suggests that in-
traocular tuberculosis can be associated with typical
features of IRVAN and must be investigated in endemic
population.
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